NeuraLace Medical ropes in $2 mln

San Diego-based NeuraLace Medical, a developer of non-opioid pain reduction treatment, has raised $2 million in funding. FusionX Ventures led the round with participation from Mooring Ventures.

15 March 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail